Literature DB >> 15338308

Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.

Nicola J Allen1, Ragnhildur Káradóttir, David Attwell.   

Abstract

A dysfunction of amino acid neurotransmitter transporters occurs in a number of central nervous system disorders, including stroke, epilepsy, cerebral palsy and amyotrophic lateral sclerosis. This dysfunction can comprise a reversal of transport direction, leading to the release of neurotransmitter into the extracellular space, or an alteration in transporter expression level. This review analyses the role of glutamate and GABA transporters in the pathogenesis and therapy of a number of acute and chronic neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338308     DOI: 10.1007/s00424-004-1318-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  100 in total

Review 1.  Neurobiology of periventricular leukomalacia in the premature infant.

Authors:  J J Volpe
Journal:  Pediatr Res       Date:  2001-11       Impact factor: 3.756

2.  GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus.

Authors:  C E Ribak; W M Tong; N C Brecha
Journal:  J Comp Neurol       Date:  1996-04-15       Impact factor: 3.215

3.  Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.

Authors:  C Bendotti; M Tortarolo; S K Suchak; N Calvaresi; L Carvelli; A Bastone; M Rizzi; M Rattray; T Mennini
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

4.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Expression of glutamate transporters in rat optic nerve oligodendrocytes.

Authors:  M Domercq; M V Sánchez-Gómez; P Areso; C Matute
Journal:  Eur J Neurosci       Date:  1999-07       Impact factor: 3.386

6.  GABA uptake and heterotransport are impaired in the dentate gyrus of epileptic rats and humans with temporal lobe sclerosis.

Authors:  P R Patrylo; D D Spencer; A Williamson
Journal:  J Neurophysiol       Date:  2001-04       Impact factor: 2.714

7.  Sequential release of GABA by exocytosis and reversed uptake leads to neuronal swelling in simulated ischemia of hippocampal slices.

Authors:  Nicola J Allen; David J Rossi; David Attwell
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

8.  Flux coupling in a neuronal glutamate transporter.

Authors:  N Zerangue; M P Kavanaugh
Journal:  Nature       Date:  1996-10-17       Impact factor: 49.962

9.  Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.

Authors:  S A Back; N L Luo; N S Borenstein; J M Levine; J J Volpe; H C Kinney
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

10.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.

Authors:  D Trotti; A Rolfs; N C Danbolt; R H Brown; M A Hediger
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

View more
  26 in total

1.  GABA-mediated spatial and temporal asymmetries that contribute to the directionally selective light responses of starburst amacrine cells in retina.

Authors:  Andrey V Dmitriev; Konstantin E Gavrikov; Stuart C Mangel
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

Review 2.  Glutamate and the biology of gliomas.

Authors:  John de Groot; Harald Sontheimer
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

3.  In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine.

Authors:  Rejane G Tavares; André P Schmidt; Jamile Abud; Carla I Tasca; Diogo O Souza
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

4.  Different pools of glutamate receptors mediate sensitivity to ambient glutamate in the cochlear nucleus.

Authors:  Yang Yang; Matthew A Xu-Friedman
Journal:  J Neurophysiol       Date:  2015-04-08       Impact factor: 2.714

5.  Enhanced astroglial GABA uptake attenuates tonic GABAA inhibition of the presympathetic hypothalamic paraventricular nucleus neurons in heart failure.

Authors:  Sudip Pandit; Ji Yoon Jo; Sang Ung Lee; Young Jae Lee; So Yeong Lee; Pan Dong Ryu; Jung Un Lee; Hyun-Woo Kim; Byeong Hwa Jeon; Jin Bong Park
Journal:  J Neurophysiol       Date:  2015-06-10       Impact factor: 2.714

6.  Evidence for a Revised Ion/Substrate Coupling Stoichiometry of GABA Transporters.

Authors:  Samantha L Willford; Cynthia M Anderson; Shelly R Spencer; Sepehr Eskandari
Journal:  J Membr Biol       Date:  2015-04-01       Impact factor: 1.843

7.  VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

Authors:  Diana Cunha-Reis; Joaquim Alexandre Ribeiro; Rodrigo F M de Almeida; Ana M Sebastião
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

8.  Role for pro-inflammatory cytokines in regulating expression of GABA transporter type 1 and 3 in specific brain regions of kainic acid-induced status epilepticus.

Authors:  Jing Su; Jian Yin; Wei Qin; Suxu Sha; Jun Xu; Changbin Jiang
Journal:  Neurochem Res       Date:  2015-02-24       Impact factor: 3.996

9.  Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI.

Authors:  Shaun D Darrah; Megan A Miller; Dianxu Ren; Nichole Z Hoh; Joelle M Scanlon; Yvette P Conley; Amy K Wagner
Journal:  Epilepsy Res       Date:  2012-07-26       Impact factor: 3.045

10.  Regulation of tonic GABA inhibitory function, presympathetic neuronal activity and sympathetic outflow from the paraventricular nucleus by astroglial GABA transporters.

Authors:  Jin Bong Park; Ji Yoon Jo; Hong Zheng; Kaushik P Patel; Javier E Stern
Journal:  J Physiol       Date:  2009-08-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.